Stock & Company Details
Arbutus Biopharma Corp $ABUS
Price:
N/A
N/A
198M
$856M
52 Week High:
N/A
10 Day Average Volume:
N/A
5.20
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
ABUS technical indicators
Latest Arbutus Biopharma Corp (ABUS) indicator readings as of 2026-10-29.
ABUS's 14-day RSI is 43.0, in neutral territory. At $4.28 it is trading 4.9% below its 200-day moving average of $4.50, and below its 50-day average of $4.72. Price sits in the middle of its Bollinger Bands ($4.02 to $4.53). ADX reads 27.9, indicating a trending market.
Overview
Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. It is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.
Finance Bot
Ask your questions
Start by typing a question below.
